Babak Eliassi-Rad is an Ophthalmology physician affiliated with Boston University. OpenAlex indexes 28 publications with 385 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Faunce Corner Rd Ste 110
N Dartmouth, MA 027471255
Telephone
508-717-0270Provider last certified this registry record 13 Jul 2023.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Glaukos CorporationProgram year20256 payments
- ABBVIE INC.Program year20256 payments
- NEW WORLD MEDICAL,INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
81.6%Prostaglandin Analog24.1%Latanoprost95%Lumigan5%Part D≥326 patientsCarbonic Anhydrase Inhibitor15.8%Dorzolamide-Timolol55%Dorzolamide Hcl36%Simbrinza4%Acetazolamide3%Brinzolamide2%Part D<11 patients+ 8 more classes in this area
Musculoskeletal
9.4%Cyclooxygenase Inhibitor9.4%Ketorolac Tromethamine100%Part D≥292 patientsCardiovascular
6.2%Beta blocker6.2%Timolol Maleate100%Part D≥102 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Five-year outcomes of selective laser trabeculoplasty: A retrospective study
Frontiers in Medicine
2023 - Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital
Journal of Ocular Pharmacology and Therapeutics
2021 - Risk factors for persistent inflammation post-laser peripheral iridotomy
Clinical ophthalmology
2021 - Inter-rater agreement on decision making in glaucoma clinical encounters
Investigative Ophthalmology & Visual Science
2020 - Patient Satisfaction for Oral versus Intravenous Sedation for Glaucoma Procedures
Investigative Ophthalmology & Visual Science
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
George O'Connor, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”